Cardiac Markers

The RAMP^® System provides a quantitative measurement of cardiac markers in whole blood to assist in the diagnosis of a heart attack.
 
Each year in North America more than six million people go to emergency rooms with severe chest pain. Only 10% of those hospitalized suffer a heart attack, and approximately 40,000 are misdiagnosed and sent home rather than admitted for treatment.
 
The total cost of unnecessary admissions and misdiagnosis is approximately $4 billion a year, and the liability costs associated with this disease are the highest in the healthcare industry.
 
RAMP is easy-to-use, cost effective, and delivers reliable results in less than 15 minutes for most assays. This point-of-care (POC) method is considerably faster than traditional laboratory results, and faster turn around translates to improved patient outcomes and reduced hospital costs. Learn more about how the RAMP System works.
 
Results from independent multi-center US clinical trials of RAMP tests for Troponin I and CK-MB demonstrated significantly improved performance over the current market leading POC system, and excellent correlation of results with main lab instruments. Utilizing proven antibody-antigen complexes, state of the art fluorescence analysis, and economical lateral flow test strips, RAMP delivers highly sensitive results without compromising accuracy and cost.
 
For more information or to book an evaluation contact our clinical sales team.